Mendon, MA, United States of America

Karen G Bulock

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 113(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Karen G. Bulock in Nucleic Acid Delivery and Cancer Treatment

Introduction: Karen G. Bulock, an accomplished inventor based in Mendon, MA, has made significant contributions to the fields of biotechnology and pharmaceuticals. With a total of eight patents to her name, Bulock focuses on developing novel approaches for nucleic acid delivery and cancer treatment, enhancing therapeutic options available to patients.

Latest Patents: Among her latest innovations are two crucial patents related to neutral nanotransporters and cancer therapy. The first, titled "Neutral Nanotransporters," involves the development of neutral lipid formulations that facilitate the delivery of nucleic acids. These formulations incorporate hydrophobically modified polynucleotides along with lipid mixtures to enhance the efficiency of nucleic acid transport. The second patent addresses "Methods for Treating Cancer Using Nucleic Acids Targeting MDM2 or MYCN." This invention involves administering nucleic acid molecules that are designed to target specific genes involved in tumor growth, thereby offering potential treatments for various types of cancer.

Career Highlights: Bulock's career has seen her contribute to leading organizations in the biotechnology sector, including Phio Pharmaceuticals Corp. and Rxi Pharmaceuticals Corporation. Her work at these companies has allowed her to be at the forefront of developing innovative solutions that address critical health challenges.

Collaborations: Throughout her career, Bulock has collaborated with esteemed professionals in her field, such as James Cardia and Anastasia Khvorova. These partnerships have facilitated the exchange of ideas and enhanced the development of her groundbreaking technologies in nucleic acid delivery and cancer treatment.

Conclusion: Karen G. Bulock's contributions to the realm of biotechnology through her innovative patents underscore her significant role as an inventor. Her work in neutral nanotransporters and cancer treatment not only reflects her dedication to advancing medical science but also holds the potential to improve patient outcomes in cancer therapy. With her expertise and continued research, the future of nucleic acid delivery systems looks promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…